Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Net Sales
12,207.44
10,260.44
8,749.43
7,781.56
6,214.43
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
12,207.44
10,260.44
8,749.43
7,781.56
6,214.43
Raw Material Cost
2,016.35
1,842.29
1,813.66
2,057.56
1,373.18
Purchase of Finished goods
1,655.69
1,409.85
809.24
813.75
654.83
(Increase) / Decrease In Stocks
-183.00
-53.67
290.74
-449.59
-247.40
Employee Cost
2,692.37
2,260.60
1,918.47
1,620.59
1,415.78
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
Other Expenses
3,008.10
2,287.69
2,016.69
1,749.88
1,369.94
Total Expenditure (Excl Depreciation)
9,189.51
7,746.76
6,848.80
5,792.20
4,566.33
Operating Profit (PBDIT) excl Other Income
3,017.93
2,513.68
1,900.63
1,989.36
1,648.10
Other Income
536.79
280.22
128.57
196.03
170.95
Operating Profit (PBDIT)
3,554.72
2,793.90
2,029.20
2,185.39
1,819.05
Interest
429.41
32.75
44.47
58.61
20.15
Exceptional Items
4.53
0.98
0.00
0.00
0.00
Gross Profit (PBDT)
3,125.31
2,761.15
1,984.73
2,126.78
1,798.90
Depreciation
621.22
378.42
325.92
166.62
118.97
Profit Before Tax
2,504.09
2,382.73
1,658.82
1,960.15
1,679.93
Tax
509.74
457.15
361.56
521.64
398.58
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,994.35
1,925.58
1,297.26
1,438.51
1,281.35
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
4.53
0.98
0.00
0.00
0.00
Net Profit
1,998.88
1,926.56
1,297.26
1,438.51
1,281.35
Share in Profit of Associates
12.24
15.21
12.42
14.45
11.68
Minority Interest
-20.16
-28.87
-27.82
-19.48
-27.61
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,990.96
1,912.90
1,281.86
1,433.48
1,265.43
Equity Capital
41.26
40.06
40.06
40.06
45.06
Face Value
1.0
1.0
1.0
1.0
1.0
Reserves
14,291.13
9,323.03
7,395.16
6,115.17
0.00
Earnings per share (EPS)
48.25
47.75
32.0
35.78
28.08
Diluted Earnings per share
49.19
47.68
32.0
35.78
32.28
Operating Profit Margin (Excl OI)
24.72%
24.5%
21.72%
25.57%
26.52%
Gross Profit Margin
25.6%
26.91%
22.68%
27.33%
28.95%
PAT Margin
16.44%
18.92%
14.97%
18.67%
20.81%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 18.98% vs 17.27% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 4.08% vs 49.23% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 20.06% vs 32.26% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 1,211.18% vs -26.35% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Mankind Pharma With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
12,207.44
23,241.50
-11,034.06
-47.48%
Other Operating Income
0.00
0.00
0.00
Total Operating income
12,207.44
23,241.50
-11,034.06
-47.48%
Raw Material Cost
2,016.35
4,372.90
-2,356.55
-53.89%
Purchase of Finished goods
1,655.69
2,150.00
-494.31
-22.99%
(Increase) / Decrease In Stocks
-183.00
-184.90
1.90
1.03%
Employee Cost
2,692.37
3,680.60
-988.23
-26.85%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
3,008.10
6,164.40
-3,156.30
-51.20%
Total Expenditure (Excl Depreciation)
9,189.51
16,183.00
-6,993.49
-43.22%
Operating Profit (PBDIT) excl Other Income
3,017.93
7,058.50
-4,040.57
-57.24%
Other Income
536.79
269.50
267.29
99.18%
Operating Profit (PBDIT)
3,554.72
7,328.00
-3,773.28
-51.49%
Interest
429.41
165.90
263.51
158.84%
Exceptional Items
4.53
-219.60
224.13
102.06%
Gross Profit (PBDT)
3,125.31
6,942.50
-3,817.19
-54.98%
Depreciation
621.22
915.80
-294.58
-32.17%
Profit Before Tax
2,504.09
6,026.70
-3,522.61
-58.45%
Tax
509.74
1,411.90
-902.16
-63.90%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
1,994.35
4,614.80
-2,620.45
-56.78%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
4.53
0.00
4.53
Net Profit
1,998.88
4,614.80
-2,615.92
-56.69%
Share in Profit of Associates
12.24
57.80
-45.56
-78.82%
Minority Interest
-20.16
-147.10
126.94
86.30%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,990.96
4,525.50
-2,534.54
-56.01%
Equity Capital
41.26
100.60
-59.34
-58.99%
Face Value
1.00
1.00
0.00
Reserves
14,291.13
23,852.50
-9,561.37
-40.09%
Earnings per share (EPS)
48.25
44.99
3.26
7.25%
Diluted Earnings per share
49.19
44.97
4.22
9.38%
Operating Profit Margin (Excl OI)
24.72%
31.27%
0.00
-6.55%
Gross Profit Margin
25.60%
30.75%
0.00
-5.15%
PAT Margin
16.44%
20.44%
0.00
-4.00%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 12,207.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 18.98% vs 17.27% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 1,990.96 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 4.08% vs 49.23% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3,017.93 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 20.06% vs 32.26% in Mar 2024
Annual - Interest
Interest 429.41 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 1,211.18% vs -26.35% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 24.72%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
